Ivan Maillard, MD, PhD, is a physician-scientist serving as the Vice-Chief for Research and a Professor of Medicine in the Division of Hematology/Oncology at the University of Pennsylvania’s Perelman School of Medicine. Dr. Maillard completed his training at the University of Lausanne and Zurich (MD Medicine), the Swiss Academy of Medical Sciences (MD-PhD, Medicine), and the University of Pennsylvania (Hematology). He then worked as an Assistant Professor and an Associate Professor at the University of Michigan. His laboratory investigates the regulation of normal and malignant hematopoiesis, bone marrow transplantation and T cell alloimmunity. Additionally, his lab focuses on the role of Notch signaling in T cell development, differentiation and function. Using mouse models of bone marrow transplantation, his laboratory discovered essential functions for Notch receptors and ligands in graft-versus-host disease with a high fundamental and translational impact. They are also interested in understanding the role of Trithorax family epigenetic regulators in hematopoiesis and leukemia.

Sources:

https://www.lls.org/award-recipient/ivan-maillard https://www.pennmedicine.org/providers/profile/ivan-maillard

Valentina Lo Sardo, PhD is an Assistant Professor in the Department of Cell and Regenerative Biology in the School of Medicine and Public Health at the University of Wisconsin–Madison. She earned her doctorate at the University of Milan, where she described a novel function of the Huntington Disease gene product, huntingtin, as a regulator of cell adhesion in the developing nervous system. She continued her training at The Scripps Research Institute in California as a postdoctoral fellow. During her postdoctoral fellowship she expanded her research interests to study the effects of age associated somatic mutations in iPSC differentiation. Her expertise spans the fields of rare disease variants, human functional genomics, stem cell differentiation potential and somatic reprogramming. Dr. Lo Sardo’s lab at UW works at the intersection of stem cells and genetics and focuses on the contributions of common genetic variations among individuals to cardiovascular disease - specifically, the 9p21.3 cardiovascular disease risk locus - as well as cancer within various cell types.